SGLT2 inhibition by intraperitoneal dapagliflozin mitigates peritoneal fibrosis and ultrafiltration failure in a mouse model of chronic peritoneal exposure to high-glucose dialysate

Added 567 days ago (06.11.2020)
Authors: Balzer, M. S., Rong, S., Nordlohne, J., Zemtsovski, J. D., Schmidt, S., Stapel, B., Bartosova, M., von Vietinghoff, S., Haller, H., Schmitt, C. P., Shushakova, N.
Source: bioRxiv
Read article